Related Experiment Video

Updated: May 27, 2026

Glycan Node Analysis: A Bottom-up Approach to Glycomics
11:36

Glycan Node Analysis: A Bottom-up Approach to Glycomics

Published on: May 22, 2016

[Congenital glycosylation disorders: a study of two patients]

R Palencia1, N Higuera, S Vázquez

  • 1Neuropediatría, Hospital Clínico, Valladolid, España. palenciar@ono.com

Anales De Pediatria (Barcelona, Spain : 2003)
|November 26, 2011
PubMed

Insights

Congenital glycosylation disorders (CGDs) are rare genetic conditions affecting glycoprotein synthesis. Early recognition is crucial for managing diverse neurological and systemic symptoms in affected children.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Congenital glycosylation disorders (CGDs) are a group of rare genetic disorders stemming from defects in glycoprotein synthesis.
  • These complex disorders can manifest with a wide range of clinical symptoms affecting multiple organ systems.

Observation:

  • This report details two pediatric cases of CGD with varying ages and genders.
  • Clinical, radiological, and laboratory findings consistent with CGD were observed in both patients.
  • One case involved a multi-year follow-up, providing longitudinal data.

Findings:

  • The presented cases highlight the diverse clinical presentations of CGD.
  • Diagnostic findings underscore the importance of considering CGD in unexplained pediatric neurological conditions.
  • Specific symptoms included psychomotor delay, hypotonia, epilepsy, and hepatic/coagulation abnormalities.

Implications:

  • Pediatricians should consider CGD in the differential diagnosis of unexplained neurological symptoms.
  • Early identification and diagnosis of CGD are essential for appropriate patient management and care.
  • Further awareness and research into CGD are vital for improving patient outcomes.
Abstract

More Related Videos

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins11:25

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...